This topic contains a solution. Click here to go to the answer

Author Question: The nurse is caring for a patient who has chronic lymphocytic leukemia and is receiving fludarabine ... (Read 21 times)

imanialler

  • Hero Member
  • *****
  • Posts: 539
The nurse is caring for a patient who has chronic lymphocytic leukemia and is receiving fludarabine (Fludara). What laboratory tests would the nurse review prior to administration of this medication?
 
  a. Complete blood cell count
  b. Serum protein levels
  c. Renal function studies
  d. Liver function studies

Question 2

The nurse would correctly describe the method of action of cell-cycle specific anticancer agents as toxic only to cells
 
  a. that are passing through a particular phase of the cell cycle.
  b. in the M phase.
  c. in the S phase.
  d. that have a high mitotic index in their natural state.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jesse.fleming

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

ANS: A
The nurse should review the CBC. Fludarabine may cause neutropenia, anemia, and thrombocytopenia.
Protein levels are not indicated.
Renal and liver function tests are not indicated, because fludarabine is not associated with toxicity of the liver or kidneys. It has been associated with pulmonary toxicity.

Answer to Question 2

ANS: A
Phase-specific agents are toxic only to cells passing through a particular phase of the cell cycle.
Cell-cycle specific anticancer agents may be toxic in either the M phase or the S phase, but the wording of the question eliminates these two choices by speaking of the action of these agents in general.
Cell-cycle specific anticancer agents are toxic to all cells regardless of their mitotic state.




imanialler

  • Member
  • Posts: 539
Reply 2 on: Jul 23, 2018
:D TYSM


irishcancer18

  • Member
  • Posts: 310
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

For a complete list of videos, visit our video library